CClinicalTrials.gg
CompletedNCT05481268Updated Aug 1, 2022

Kinesiotaping and Stretching on SKM and Upper Trapezius Muscle in TMD Patients

An interventional study of Kinesiotaping Group and Stretching Group in TMJ Disc Disorder and Myofascial Pain, sponsored by Istanbul Arel University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-08-01.

Sponsored by Istanbul Arel University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years 4 months after the study started (first participant enrolled Mar 2018, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Purpose: This study determined the effects of Kinesiotaping and Stretching on pain, cervical joint range of motion and functional status in patients with myofascial pain due to temporomandibular joint disorder.

Methods: 33 patients with myofascial pain due to temporomandibular joint disorder were included in the study. The patients were divided into three groups by simple randomization (Kinesiotaping group, Stretching group and Control group). Patients in the Kinesiotaping and Stretching groups received application for their Upper Trapezius and Sternocleidomastoid muscles twice a week for two weeks by the same physiotherapist. No application was made to the Control group. Cervical joint range of motion, muscle strength and pain were evaluated. Additionally, algometry tests and functional evaluation were performed. The tests were performed in the Kinesiotaping and Stretching groups before the applications and at the end of week 1 and week 2, on the other hand Control group evaluated before the application and at the end of week 2.

Read the detailed description

This study is my master's thesis that I conducted in 2018. Our prospective clinical study was approved by the Non-Interventional Ethics Committee. The study was conducted at Dentistry Prosthetic Odontotherapy Outpatient Clinic between February 2018 and April 2018. Volunteering 33 patients between the ages of 18 to 60 years and who applied clinics and were diagnosed with myofascial pain due to TMJ disorder according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) classification were included in the study. The patients were divided into groups using simple randomization method. There are 11 patients in groups. Blinding was ensured by patients and dentist were unaware the type of physiotherapy treatment application. Patient evaluation was repeated 3 times: before the treatment, at the end of week 1, and at the end of week 2 of the treatment.

In our study, the effects of conservative treatment options used in 'treatment of TMD on 'disease symptoms were examined compared with the control group. A 2-week follow-up was foreseen for the acute impact outcomes of the study.

02

Conditions studied

  • TMJ Disc Disorder
  • Myofascial Pain

Keywords

  • Temporomandibular pain
  • Kinesiotape
  • Stretching
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 33 is below the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Istanbul Arel University is the lead sponsor of 44 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age between 18 and 60 years
  • Myofascial pain according to RDC/TMD
  • Natural posterior occlusion and volunteering
  • Being informed and signing the consent to participate in the research.

Exclusion criteria

Exclusion Criteria:

  • Presence of dentofacial anomalies
  • Arthralgia
  • Disk displacement
  • General inflammatory connective tissue diseases (e.g. rheumatoid arthritis)
  • Psychiatric disease
  • Tumor
  • Orofacial disease symptoms (neuralgia, migraine, etc.)
  • Local skin infection
  • Using regular analgesic
  • Fibromyalgia
  • History of TMJ-related surgery
  • Findings of allergy related to Kinesiotape.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Kinesiotaping Group

    In the Kinesiotaping Group patients had muscle technique-inhibition method. An 'I' shaped tape was used for both SCM and upper trapezius.

    Other: Kinesiotaping Group

  • Experimental
    Stretching Group

    The patient was stretched in a relaxed and supported position and physiotherapist positioned the patient passively for stretching.

    Other: Stretching Group

  • Other
    Control Group

    Control Group patients, after the assessment by the dentist, the treatment method approved by the dentist was performed.

    Other: Control Group

Interventions

  • OtherKinesiotaping Group

    In the Kinesiotaping Group patients had muscle technique-inhibition method. An 'I' shaped tape was used for both SCM and upper trapezius. The tension of the tape was adjusted between 20 and 25% and the application was performed in the longest position of the muscle. The inhibition technique was applied from the insertion to the origin of the muscle. The tape was applied to cover the trigger points where pain was felt. For upper trapezius, the muscle was taped in the opposite direction on the cervical region in lateral flexion, slight flexion, shoulder depression and using the muscle technique with the I tape. For SCM muscle, the tape was applied on the muscle in the opposite direction on the cervical region with positioning in lateral flexion, extension and ipsilateral rotation using the muscle technique with I tape Taping was applied every 3 days and totally in 4 cycles.

  • OtherStretching Group

    In our application, 3 cycles of 20 seconds of stretches were applied to upper trapezius and SCM muscle. The patient was stretched in a relaxed and supported position and physiotherapist positioned the patient passively for stretching. For the SCM muscle, stretching was achieved in the positions of contralateral lateral flexion, ipsilateral rotation and extension. For upper trapezius, stretching was performed in flexion and lateral flexion. Stretching was performed every 3 days in 4 cycles in total.

  • OtherControl Group

    Control Group patients, after the assessment by the dentist, the treatment method approved by the dentist was performed. The assessment was performed before treatment, at the end of week 1 and at the end of week 2.

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    The subjective pain intensity of the patients was assessed with the Visual Analogue Scale. The Visual Analog Scale includes scoring between 0 and 10. The corresponding numbers from 0 to 10 were explained to the patients. It was explained that the absence of pain was 0, the most severe pain felt was 10, and moderate pain was 5. For the Upper Trapezius and SCM muscle, the patients were asked to mark their resting and functional pain from the scale.Additionally, pain during palpation of the upper trapezius and sternocleidomastoid muscle was assessed with algometry.

    Time frame: 2 weeks

  2. Range of Motion

    The range of motion of the cervical joint was assessed using a goniometer

    Time frame: 2 weeks

  3. Research Diagnostic Criteria for Temporomandibular Disorders

    Klinik değerlendirme formunun içeriğinde ağrının nedeni ve ağrının tarafı, ağız açılma şekli ve açılma miktarı, eklem sesleri, eksantrik hareket miktarları ve hareket sırasındaki ağrı durumları, eklem sesleri ve kas ağrıları palpasyonla değerlendirildi. .

    Time frame: 2 week

  4. Muscle Strength

    Cervical muscle strength was assessed manually

    Time frame: 2 week

  5. Mouth Opening Distance

    The mouth opening of the patients was measured in millimeters for the distance between anterior incisors of the upper and lower jaws.

    Time frame: 2 weeks

Secondary outcomes

  1. The Patient Health Questionnaire

    The Patient Health Questionnaire was used for comparison in the assessments are two of the subtests of the RDC/TMD questionnaire. The purpose of those tests was to obtain numerical data and to observe the comparison objectively.

    Time frame: 2 weeks

  2. Jaw Functional Limitation Scale

    It has three levels of functional limitation, including chewing (6 items), jaw mobility (4 items), and verbal and emotional expression (10 items). Each item is rated on a numeric rating scale from 0 to 10. 0, no limitation; 10 indicates severe limitation.

    Time frame: 2 weeks

07

Study locations

1 site
  • Arel University
    Istanbul, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05481268
Lead sponsor
Istanbul Arel University
Responsible party
Ozge Baykan Copuroglu (Prelector/ Physiotherapist, Istanbul Arel University) — Principal investigator
First posted
Aug 1, 2022
Start date
Mar 15, 2018
Primary completion
Jul 19, 2018
Completion
Jul 19, 2018
Last update
Aug 1, 2022

Study contacts

Ozge Baykan Copuroglu, MSc
principal investigator · Istanbul Arel University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion